Liraglutide attenuates obese-associated breast cancer cell proliferation via inhibiting PI3K/Akt/mTOR signaling pathway - Alanteet, Alaa; Attia, Hala; Alfayez, Musaed; Mahmood, Amer; Alsaleh, Khalid; Alsanea, Sary (Saudi pharmaceutical journal, 2024)
Keywords: Akt; Breast Cancer; Liraglutide; mTOR; Obesity; PI3K; PBS; Obesity; BC; CM; siRNA; Akt; ADSCs-CM; Breast Cancer; SC; BSA; DMEM; SIRT-1; p-Akt; PI3K; ADSCs; FBS; mTOR; LGT; AMPK; Liraglutide; BMI; GLP-1R